News
Replimune said the agency had issued a complete response letter regarding the company’s biologics license application for RP1 ...
Investor's Business Daily on MSN6d
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its StockReplimune stock cratered Tuesday after the Food and Drug Administration unexpectedly rejected its experimental melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback